IONS

Ionis Pharmaceuticals News

Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Small Cap Basic
Monthly Subscription
for only
$33.03
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
$67.09
VAT not included
Company Name Stock Ticker Symbol Market Type
Ionis Pharmaceuticals Inc IONS NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.13 -0.43% 29.88 20:00:01
Open Price Low Price High Price Close Price Prev Close
29.70 29.45 30.69 29.88 30.01
more quote information »

Recent News

Date Time Source Heading
1/21/202208:45TRMNAnalysts Are Bullish on These Healthcare Stocks: Encompass..
1/19/202207:05PRNUSIonis strengthens leadership team with appointments of..
1/18/202208:03SEEKIonis' says Roche eyeing phase 2 tominersen trial in..
1/18/202200:05PRNUSIonis' partner to evaluate tominersen for Huntington's..
1/05/202218:01EDGARStatement of Changes in Beneficial Ownership (4)
1/05/202218:00EDGARStatement of Changes in Beneficial Ownership (4)
1/05/202218:00EDGARStatement of Changes in Beneficial Ownership (4)
1/05/202218:00EDGARStatement of Changes in Beneficial Ownership (4)
1/05/202218:00EDGARStatement of Changes in Beneficial Ownership (4)
1/05/202217:59EDGARStatement of Changes in Beneficial Ownership (4)
1/05/202217:59EDGARStatement of Changes in Beneficial Ownership (4)
1/05/202217:59EDGARStatement of Changes in Beneficial Ownership (4)
1/05/202207:05PRNUSIonis to present at 40th Annual J.P. Morgan Healthcare..
1/04/202207:34GLOBEBiogen Exercises Option with Ionis to Develop and..
1/04/202207:30PRNUSBiogen Exercises Option with Ionis to Develop and..
12/29/202102:54DJNAstraZeneca, Ionis Agree on Deal to Develop and..
12/29/202102:15SEEKIonis and AstraZeneca close eplontersen development deal
12/29/202102:00PRNUSIonis and AstraZeneca close deal to develop and..
12/14/202111:50SEEKIonis upgraded to outperform at William Blair on potential..
12/07/202106:16SEEKIonis teams up with Astrazeneca to develop and commercialize..
12/07/202106:04EDGARCurrent Report Filing (8-k)
12/07/202103:09DJNAstraZeneca to Work with Ionis on Eplontersen Drug
12/07/202102:00PRNUSIonis and AstraZeneca to develop and commercialize..
12/02/202115:03PRNUSIonis to hold virtual investor day event
11/26/202116:06EDGARCurrent Report Filing (8-k)
11/26/202108:16TRMNIonis Reveals Results study of vupanorsen
11/25/202104:10TRMNIonis Pharmaceuticals (IONS) Gets a Hold Rating from Leerink..
11/24/202109:30EDGARCurrent Report Filing (8-k)
11/24/202107:29DJNIonis Pharma: Clinical Study of Vupanorsen Meets Primary..
11/24/202107:20SEEKIonis says that Pfizer reports topline results from Phase 2b..
11/24/202106:30PRNUSIonis announces that Pfizer reports topline results from..
11/18/202113:30PRNUSIonis initiates Phase 3 clinical program of donidalorsen in..
11/12/202107:05PRNUSIonis' antisense therapies to be featured at the American..
11/09/202107:05PRNUSIonis to present at upcoming virtual investor conferences
11/07/202107:05PRNUSPhase 2 study results of Ionis' novel antisense treatment..
11/03/202115:38EDGARQuarterly Report (10-q)
11/03/202108:54SEEKIonis sees Q3 net loss more than double due to restructured..
11/03/202107:05SEEKIonis Pharmaceuticals EPS misses by $0.05, misses on revenue
11/03/202107:00PRNUSIonis reports third quarter 2021 financial results and..
11/02/202111:33SEEKIonis Pharmaceuticals Q3 2021 Earnings Preview
11/02/202107:16SEEKIonis initiates late-stage olezarsen hypertriglyceridemia..
11/02/202107:05PRNUSIonis initiates pivotal Phase 3 clinical study of olezarsen..
10/20/202107:05PRNUSIonis to hold third quarter 2021 financial results webcast
10/19/202118:30EDGARStatement of Changes in Beneficial Ownership (4)
10/19/202118:30EDGARStatement of Changes in Beneficial Ownership (4)
10/19/202118:29EDGARStatement of Changes in Beneficial Ownership (4)
10/18/202114:31EDGARCurrent Report Filing (8-k)
10/18/202110:55DJNIonis Pharma Shares Drop 12% After Tofersen Study Misses..
10/17/202116:20PRNUSIonis' partner Biogen provides update on tofersen Phase 3..
10/14/202116:06GLOBETopline Results from Tofersen Phase 3 Study and its Open..
See more news about this stock »
Your Recent History
NASDAQ
IONS
Ionis Phar..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20220123 10:26:29